COMMUNIQUÉS West-GlobeNewswire

GENFIT : Franchissement d'une étape clé de l'étude de phase 3 RESOLVE-IT avec le recrutement de la cohorte d'analyse intermédiaire
11/04/2018
GENFIT : Franchissement d'une étape clé de l'étude de phase 3 RESOLVE-IT avec le recrutement de la cohorte d'analyse intermédiaire Le recrutement de la cohorte de patients en vue de la mise sur le marché anticipée a été [...]
ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.
11/04/2018
Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands - 11 April 2018 As of today [...]
Assembly Biosciences to Host Conference Call on April 12 to Review ABI-H0731 Interim Phase 1b Data in HBV Patients Featured in Late-Breaker Poster at EASL
10/04/2018
INDIANAPOLIS and SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
Extendicare Announces Timing of 2018 First Quarter Results and Conference Call
10/04/2018
MARKHAM, Ontario, April 10, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the first quarter of 2018, after [...]
Nextech to Explore Ways to Reduce Administrative Burden at ASCRS-ASOA Annual Symposium & Congress 2018
10/04/2018
Predictive charting functionalities among new IntelleChartPRO features highlighted at the show TAMPA, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for [...]
Avivagen Announces Results from Its Annual General Meeting
10/04/2018
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
Analogic to Be Acquired by an Affiliate of Altaris Capital Partners for $84.00 per Share or $1.1 Billion in Cash
10/04/2018
Comprehensive Alternatives Review Process to Maximize Stockholder Value Culminates in Strategic Transaction Represents 25% Premium to Analogic’s Stock Price of $67.45 as of June 7, 2017, the Day Following Analogic’s [...]
OraSure Technologies Appoints New Senior Vice President, Business Development
10/04/2018
BETHLEHEM, Pa., April 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that David Rappaport has been [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
10/04/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - April 10, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Brain Armor Announces Distribution at Walmart Inc.
10/04/2018
Brookfield, WI , April 10, 2018 (GLOBE NEWSWIRE) -- Brain Armor Inc., an innovative nutrition company dedicated to improving cognitive health and performance on every field of play and a subsidiary of Trident Brands, [...]
NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-CLINICAL RESEARCH IN LUNG CANCER COMBINING NBTXR3 AND NIVOLUMAB
10/04/2018
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-CLINICAL RESEARCH IN LUNG CANCER COMBINING NBTXR3 AND NIVOLUMAB Paris, France and Cambridge, Massachusetts [...]
NANOBIOTIX : NANOBIOTIX ET L'UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER LANCENT UN PROJET DE RECHERCHE PRÉCLINIQUE EN IMMUNOTHÉRAPIE COMBINANT NBTXR3 ET NIVOLUMAB DANS LE CANCER DU POUMON
10/04/2018
NANOBIOTIX ET L'UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER LANCENT UN PROJET DE RECHERCHE PRÉCLINIQUE EN IMMUNOTHÉRAPIE COMBINANT NBTXR3 ET NIVOLUMAB DANS LE CANCER DU POUMON Paris, France et Cambridge, Massachusetts [...]
NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief
10/04/2018
WALTHAM, Mass., April 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ), today reported publication of results from a clinical study of Quell® in the Journal of Pain Research. The paper is titled “ [...]
Bee Prepared: How to Treat a Bee Sting -- American Academy of Dermatology
10/04/2018
ROSEMONT, Ill., April 10, 2018 (GLOBE NEWSWIRE) -- It can happen fast. One minute the kids are all playing peacefully outside on a warm, spring day. The next minute a piercing scream reveals that one of them has been [...]
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
10/04/2018
Company Announcement Copenhagen, Denmark; April 10, 2018 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on April 10, 2018, the Company’s Board of Directors met to constitute itself. Mats [...]
S. Parikh Mars, CEO of Progressive Care Returns to Uptick Newswire’s "Stock Day" Podcast with Everett Jolly
10/04/2018
PHOENIX, April 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD) (the “Company”), a healthcare services and technology company, reports progress in all areas of focus. “The Company’s purchase of the Palm [...]
Scythian Biosciences Announces Details of 4-for-1 Stock Split
10/04/2018
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) is pleased to announce details of the 4-for-1 stock split [...]
Dennis Shin, Former Advisory Board Executive, Joins Syapse as Chief Commercial Officer
10/04/2018
Syapse’s executive team continues to grow with Shin’s strong experience partnering with health systems SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Syapse, a leading precision medicine company, announced today that [...]
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Finish to 2017 and Operational Developments for 2018 on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly
10/04/2018
PHOENIX, April 10, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly [...]

Pages